Abstract:Background: Allergic rhinitis (AR) is a Th2 predominant disease, and its pathogenic mechanism is still poorly understood. CD4(+)CD25(+) T cells account for approximately 5% to 10% peripheral CD4(+) T cells and has been shown to regulate the activation of effector T cells in the periphery. The activity of CD4(+)CD25(+) T cells is associated with the transcription factor Foxp3. The present study aimed to evaluate the possible role of CD4(+)CD25(+) T cells as well as Foxp3 in the pathogenesis of AIL Methods. Nasal tissues and peripheral blood mononuclear cells (PBMCs) were obtained from 17 patients with AR and 11 control subjects. Foxp3 was detected in nasal tissues by immunohistochemistry and real-time reverse transcription-polymerase chain reaction (RT-PCR). CD4(+)CD25(+) T cells and Foxp3 were evaluated in PBMCs by using flow cytometry. Concentrations of interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) were measured by enzyme-linked immunosorbent assay (ELISA) in cultured PBMCs in the presence or absence of stimulation with phorbol ester (PMA) and lonomycin. Results. The numbers of Foxp3+ cells was 129.5 +/- 35.6 and 44.2 +/- 20.5 cells/mm(2) in nasal mucosa of two groups (P <.05). There were less Foxp3+ lymphocytes and decreased Foxp3 mRNA in AR compared with the control (P <.05). The frequencies of the CD4(+)CD25(+) population in PBMCs of two groups were 1.99 +/- 0.95% and 3.55 +/- 1.27% (P <.05). There was significant difference in the frequencies of the Foxp3(+)CD4(+) CD25(+) population (1.81 +/- 0.77 vs 3.37 +/- 1.04, P <.05) and mean fluorescence intensity (MFI) of Foxp3 (5.93 +/- 2.64 vs 11.72 +/- 4.29, P <.05) in PBMCs of two groups. After stimulation, the concentrations of IL-2 and IFN-gamma were 182.72 +/- 85.11 pg/mL and 348.94 +/- 151.88 pg/mL in PBMCs with AR, while those were 90.6 +/- 61.5 pg/mL and 155.64 +/- 68.33 pg/mL in controls (P <.05). Conclusion: Our results indicate that CD4(+) CD25(+) regulatory T cells as well as Foxp3 may play a crucial role in immunological imbalance of AR. These findings suggest that increasing Foxp3 and CD4(+)CD25(+) T cells have the potential to be new therapeutic targets for the treatment of AR.

Inhibition of DNA Methyltransferase DNMT1 Reverses Th2 Response Polarisation and Alleviates Allergic Rhinitis

Assessment of Tumor Growth Factor-Β1 Neutralizing Antibody in the Treatment of Allergic Rhinitis and Asthma.

Immunomodulation in allergic rhinitis: Insights from Th2 cells and NLRP3/IL-18 pathway

Inhibition of dendritic cell autophagy alleviates the progression of allergic rhinitis by inhibiting Th1/Th2/Th17 immune imbalance and inflammation

Ten-eleven translocation 2 modulates allergic inflammation by 5-hydroxymethylcytosine remodeling of immunologic pathways

A possible role of CD4+CD25+ T cells as well as transcription factor Foxp3 in the dysregulation of allergic rhinitis.

Immunoregulatory role of tolerogenic dendritic cells in allergic rhinitis in mice

Regulatory Effect of Microrna-135A on the Th1/Th2 Imbalance in a Murine Model of Allergic Rhinitis.

Notch2-dependent GATA3+Treg cells alleviate allergic rhinitis by suppressing the Th2 cell response

Fine Particulate Air Pollution Epigenetically Affects TET1 Expression in Dendritic Cells and Exacerbates the Inflammation of Allergic Rhinitis

Changes in Percentage of GATA3+regulatory T Cells and Their Pathogenic Roles in Allergic Rhinitis

Ten-Eleven Translocation (TET) Enzymes Modulate the Activation of Dendritic Cells in Allergic Rhinitis.

Inverse association between T-cell immunoglobulin and mucin domain-1 and T-bet in a mouse model of allergic rhinitis.

Notch2 Suppresses the Development of Allergic Rhinitis by Promoting FOXP3 Expression and Treg Cell Differentiation

Derp1-modified dendritic cells attenuate allergic inflammation by regulating the development of T helper type1(Th1)/Th2 cells and regulatory T cells in a murine model of allergic rhinitis

Antagonism of m3 Alleviates Type 2 Inflammation in Allergic Rhinitis Mice.

Experimental observation of the effect of immunotherapy on CD4+ T cells and Th1/Th2 cytokines in mice with allergic rhinitis

Allergic Inflammation is Exacerbated by Allergen-Induced Type 2 Innate Lymphoid Cells in a Murine Model of Allergic Rhinitis.

MicroRNA-150-5P regulates Th1/Th2 cytokines expression levels by targeting EGR2 in allergic rhinitis

Nasal Mucosa Remodeling and Expression of Transcription Factors T-bet/GATA-3 in Allergic Rhinitis Mouse Model

Microrna-106b Regulates Pro-Allergic Properties of Dendritic Cells and Th2 Polarisation by Targeting Early Growth Response-2 in Vitro